Category: il6 elisa

July 13, 2021

pEGFP Vectors

therapy is a novel field of research in the medical and biological sciences and has gradually developed in conjunction with the recent advances in recombinant DNA technology. The application of vectors is a crucial step in gene therapy. There are two types of vectors: integrated and non-integrated vectors. Integrated vectors facilitate the insertion of mutations, and may be responsible for diseases arising as a result […]

August 24, 2020

Research for Disulfide-Linked, Self-Immolating Subsequent-Technology Antibody Drug

Conjugation Site Influences Antibody-Conjugated Drug PK Assays: Case Studies for Disulfide-Linked, Self-Immolating Next-Generation Antibody Drug Conjugates   Immunoaffinity (IA) LC-MS/MS pharmacokinetic (PK) assays are widely used in the field for antibody drug conjugates (ADCs) containing peptide linkers that are enzymatically cleavable, such as MC-ValCit-PAB. Conjugate PK assay strategies for these ADCs involve cleavage with cathepsin B or papain to release and measure the antibody-conjugated drug (acDrug) concentration. However, […]

June 29, 2020

Hello world!

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!